UBS Initiates Coverage On Solid Biosciences with Buy Rating, Announces Price Target of $20

Benzinga · 1d ago
UBS analyst Joon Lee initiates coverage on Solid Biosciences (NASDAQ:SLDB) with a Buy rating and announces Price Target of $20.